Head-to-Head

Eli Lilly & Co. vs. Lyell Immunopharma, Inc. Common Stock

LLY

Eli Lilly & Co.

$1417.99 +0.61%

VS LYEL

Lyell Immunopharma, Inc. Common Stock

$15.43 +43.27%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

LLYLYEL
Market Cap $1.26 trillion $263.92 million

LLY leads on 1 of 1 size & scale factors.

Dividend

LLYLYEL
Dividend Yield 0.49% —

LLY and LYEL split the dividend factors evenly.

Risk & Sentiment

LLYLYEL
Short Interest 1.29% 5.38%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: LLY overview, LLY financials, LYEL overview, LYEL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.